Compounds > gliclazide
Page last updated: 2024-10-27

gliclazide and Atypical Mycobacterial Infection, Disseminated

gliclazide has been researched along with Atypical Mycobacterial Infection, Disseminated in 1 studies

Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kihara, Y1
Otsuki, M1

Other Studies

1 other study available for gliclazide and Atypical Mycobacterial Infection, Disseminated

ArticleYear
Interaction of gliclazide and rifampicin.
    Diabetes care, 2000, Volume: 23, Issue:8

    Topics: Aged; Antibiotics, Antitubercular; Clarithromycin; Diabetes Mellitus, Type 2; Drug Interactions; Dru

2000